Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Zhang

Showing results (411-420 of 429) with videos related to

Pageof 43
Sort By:
Med (New York, N.Y.)|March 28, 2026
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapyHailong Liu, Yu Su, Jiao Zhang, et al.
Journal of Medicinal Chemistry|September 9, 2021
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating CancerThomas D Aicher, Chad A Van Huis, Alexander R Hurd, et al.
Therapeutic Advances in Medical Oncology|July 24, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populationsJun Wang, Bicheng Zhang, Ling Peng, et al.
Cell Reports. Medicine|January 14, 2025
High cellular plasticity state of medulloblastoma local recurrence and distant disseminationHailong Liu, Jing Zhang, Ziwei Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 studyZhengbo Song, Ziming Li, Yiping Zhang, et al.
Chinese Medical Journal|December 4, 2003
Consensus for the management of severe acute respiratory syndromeNanshang Zhong, Yanqing Ding, Yuanli Mao, et al.
Thoracic Cancer|October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitorWenxian Wang, Qian Wang, Chunwei Xu, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.
Pageof 43

Showing results (411-420 of 429) with videos related to

Sort By:
Pageof 43
Med (New York, N.Y.)|March 28, 2026
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapyHailong Liu, Yu Su, Jiao Zhang, et al.
Journal of Medicinal Chemistry|September 9, 2021
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating CancerThomas D Aicher, Chad A Van Huis, Alexander R Hurd, et al.
Therapeutic Advances in Medical Oncology|July 24, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populationsJun Wang, Bicheng Zhang, Ling Peng, et al.
Cell Reports. Medicine|January 14, 2025
High cellular plasticity state of medulloblastoma local recurrence and distant disseminationHailong Liu, Jing Zhang, Ziwei Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 studyZhengbo Song, Ziming Li, Yiping Zhang, et al.
Chinese Medical Journal|December 4, 2003
Consensus for the management of severe acute respiratory syndromeNanshang Zhong, Yanqing Ding, Yuanli Mao, et al.
Thoracic Cancer|October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitorWenxian Wang, Qian Wang, Chunwei Xu, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.
Pageof 43